Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.99	69.8	57.42	68.18	126.91
Short-Term Investments	-	-	-	-	0.77
Cash & Short-Term Investments	40.99	69.8	57.42	68.18	127.68
Cash Growth	-41.27%	21.56%	-15.78%	-46.60%	298.48%
Other Receivables	1.98	3.25	3.73	2.31	2.46
Receivables	1.98	3.25	3.73	2.31	2.46
Prepaid Expenses	0.38	0.27	0.97	3.78	3.79
Other Current Assets	1.66	1.44	1.64	0.92	0.55
Total Current Assets	45.02	74.76	63.76	75.2	134.49
Property, Plant & Equipment	0.38	0.98	1.65	2.22	3.43
Other Intangible Assets	0.52	0.64	1.09	-	33.26
Total Assets	45.92	76.39	66.5	77.41	171.18
Accounts Payable	1.43	2.68	2.35	3.49	3.09
Accrued Expenses	2.35	4.57	5.75	5.64	5.44
Current Portion of Long-Term Debt	-	5.54	-	13.33	-
Current Portion of Leases	0.2	0.71	0.65	0.56	0.84
Current Income Taxes Payable	-	-	-	-	2.06
Other Current Liabilities	0.33	0.36	0.74	1.36	5.55
Total Current Liabilities	4.3	13.85	9.49	24.38	16.98
Long-Term Debt	-	-	4.39	-	19.48
Long-Term Leases	-	0.19	0.91	1.48	2.38
Other Long-Term Liabilities	0.7	1.39	1.18	0.16	13.18
Total Liabilities	5	15.42	15.96	26.01	52.02
Common Stock	3.14	3.06	2.78	2.48	2.38
Additional Paid-In Capital	549.62	539.64	486.11	476.52	335.08
Retained Earnings	-501.02	-462.88	-419.63	-404.58	-402.11
Treasury Stock	-	-	-1.23	-1.34	-
Comprehensive Income & Other	-10.82	-18.85	-17.49	-21.69	183.82
Shareholders' Equity	40.92	60.97	50.54	51.4	119.16
Total Liabilities & Equity	45.92	76.39	66.5	77.41	171.18
Total Debt	0.2	6.43	5.95	15.37	22.69
Net Cash (Debt)	40.79	63.37	51.47	52.81	104.99
Net Cash Growth	-35.63%	23.13%	-2.54%	-49.70%	1289.80%
Net Cash Per Share	0.26	0.43	0.39	0.44	0.95
Filing Date Shares Outstanding	159.62	159	140.01	124.74	116.73
Total Common Shares Outstanding	159.13	155.15	140	124.74	116.73
Working Capital	40.72	60.92	54.27	50.82	117.51
Book Value Per Share	0.26	0.39	0.36	0.41	1.02
Tangible Book Value	40.4	60.33	49.45	51.4	85.9
Tangible Book Value Per Share	0.25	0.39	0.35	0.41	0.74
Machinery	0.46	0.49	0.5	0.61	0.48
Leasehold Improvements	0.76	0.71	0.71	0.68	0.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.